Alzheimer's disease related copper(II)-β-amyloid peptide exhibits phenol monooxygenase and catechol oxidase activities
Alzheimer's disease related copper(II)-β-amyloid peptide exhibits phenol monooxygenase and catechol oxidase activities
复制标题
DOI:
10.1002/anie.200501013
复制
发表时间:
2005-01-01
影响因子:
16.6
通讯作者:
Ming, LJ
中科院分区:
文献类型:
--
作者:
da Silva, GFZ;Ming, LJ
Over the past few years an enormous effort has been directed toward the investigation of the metal-dependent mechanisms that lead to the neuropathology of Alzheimer s disease (AD).[1] The self-assembled metallo-β-amyloid (Aβ) peptide fibrils are the hallmark of this disease [2] and have been attributed to FeIII-and CuII-centered generation of H2O2 under reducing conditions. The latter, H2O2, has been postulated to be of significant importance in connection with neuropathy in AD.[3, 4] However, an area of oversight has been the detailed chemical processes associated with the neuropathology of AD, besides the generally acclaimed assault by ROS (reactive oxygen species; eg H2O2).[5] Hence, a better understanding of metal-centered redox chemistry and the mechanism for the generation of ROS and their fate can provide insight into potential strategies for the prevention and treatment of AD. Several examples of redox chemistry in biological systems are known to be associated with di-or multinuclear “Type-3” Cu oxidases,[6] which may be related to the redox activity of CuIIAβ.[1–4] A number of chemical model systems that target Type-3 copper centers have successfully been demonstrated to contain highly active isoelectronic copper–dioxygen species (ie CuII2-μ-η1: η1-peroxo, CuII 2-μ-η2: η2-peroxo, and CuIII 2-bis-μ-oxo), which are responsible for copper-dependent oxidation and hydroxylation reactions.[6–9] Despite extensive modeling studies, peptide mimics of these enzymes have apparently been excluded from the studies. CuIIAβ seems to fill the gap as it is a naturally occurring Cu–peptide complex demonstrated to exhibit oxygen-associated redox chemistry,[1–4] although details about its oxygen binding and activation mechanisms are lacking. Herein, we present results which bring together two distinct fields of research: Alzheimer s disease and Type-3 copper centers. The results elucidate that the CuII complex (CuAβ1–20) of the icosapeptidyl metalbinding domain of Aβ (DAEFR5HDSGY10EVHHN15-KLVFF20) exhibits metal-centered redox chemistry that is consistent with the mechanisms of the Type-3 copper enzymes, namely, phenol monooxygenase (eg tyrosinase) and catechol oxidase.The metal-centered redox chemistry of CuAβ1–20 was probed using catechol and the more-inert phenol as substrates.[10, 11] The oxidation of catechol under aerobic conditions reached a plateau at low mm concentrations, and the saturation profile fits well to pre-equilibrium kinetics [Eqs.(1) and (2)][12] to afford the rate constant kcat= 0.154 sÀ1, the dissociation constant K’app= 0.35 mm (Figure1a), and a significant second-order rate constant kcat/K’app= 440mÀ1 sÀ1 (cat= catalytic, app= apparent). As the formation of quinone from catechol is a two-electron oxidative process, the reaction is expected to follow the two-electron dinuclear reaction pathway for catechol oxidase,[13] wherein the binding of catechol to the active-site dicopper (ii) center results in the reduction of the center to yield dicopper (i) with concomitant production of o-quinone. The reduced dicopper (i) center can bind dioxygen to afford the active peroxo-bridged dicopper (ii) center, which can further oxidize a subsequently bound substrate. H2O2 can also be generated in this reaction pathway from the peroxobridged dicopper (ii) center in the presence of a reducing agent such as the substrate itself. This pathway for the production of H2O2 under reducing conditions is consistent with previous observations in AD studies.[3] The catechol oxidase like mechanism has also been observed in kinetic studies of several chemical model systems [14] and in the oxidation of polyphenols by …